Petermeier K, Szurman P
Universitätsaugenklinik Tübingen, 72076, Tübingen.
Ophthalmologe. 2007 May;104(5):399-404, 406-8. doi: 10.1007/s00347-007-1511-3.
Our purpose in this study was to assess the postoperative subjective and objective results after implantation of the Acrysof ReSTOR lens and to evaluate the advantages and limitations of the apodized diffractive optic design of this new multifocal intraocular lens (MIOL).
Phakoemulsification and implantation of an Acrysof ReSTOR was performed in 55 eyes of 32 patients. All patients were examined after a mean period of 7.9+/-1.9 months. The accuracy of lens calculation was evaluated for the Haigis, Holladay I, and SRK-T formulas. Uncorrected and corrected visual acuity for distance and for intermediate and near vision were assessed, as was stereoacuity. In addition, contrast sensitivity was tested under photopic and mesopic conditions, with and without glare. The patients were asked about dysphotic phenomena such as halos, glare or flare, and night vision using a standardized evaluation. The degree to which patients were able to manage without spectacles after the surgery was also documented.
The median monocular uncorrected visual acuity (UCVA) for distance was 20/25 (LogMAR 0.05) while the binocular UCVA was 20/20 (LogMAR 0). The monocular uncorrected acuity for near vision was 20/25 (LogMAR 0.1), the binocular near visual acuitiy was 20/20 (LogMAR 0), while the intermediate monocular visual acuity was 20/50 (LogMAR 0.4) and the binocular, 20/32 (LogMAR 0.2). Contrast sensitivity was within the normal range. Dysphotic phenomena were noted by 66% of patients but were so slight as not to cause any problem at all in 59%. For close work and distance vision 84% of all patients needed no correcting glasses, while 78% did not need to use glasses for intermediate vision.
The Acrysof ReSTOR provides excellent uncorrected visual acuity for distance and near vision and the level of patient satisfaction achieved with it is good.
本研究的目的是评估植入Acrysof ReSTOR人工晶状体后的术后主观和客观结果,并评估这种新型多焦点人工晶状体(MIOL)的变迹衍射光学设计的优点和局限性。
对32例患者的55只眼进行了白内障超声乳化吸除联合Acrysof ReSTOR人工晶状体植入术。所有患者在平均7.9±1.9个月后接受检查。评估了Haigis、Holladay I和SRK-T公式的晶状体计算准确性。评估了远、中、近视力的未矫正和矫正视力,以及立体视。此外,在明视和暗视条件下,有眩光和无眩光时测试了对比敏感度。使用标准化评估询问患者关于光晕、眩光或光斑等畏光现象以及夜间视力。还记录了患者术后无需眼镜的自理程度。
单眼远视力的未矫正视力中位数(UCVA)为20/25(LogMAR 0.05),双眼UCVA为20/20(LogMAR 0)。单眼近视力的未矫正视力为20/25(LogMAR 0.1),双眼近视力为20/20(LogMAR 0),而单眼中视力为20/50(LogMAR 0.4),双眼为20/32(LogMAR 0.2)。对比敏感度在正常范围内。66%的患者有畏光现象,但其中59%的患者症状非常轻微,根本没有造成任何问题。对于近距离工作和远视力,84%的患者无需矫正眼镜,而78%的患者中视力无需使用眼镜。
Acrysof ReSTOR人工晶状体提供了出色的远、近未矫正视力,患者满意度良好。